Northeast Financial Consultants’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $575K | Hold |
1,500
| – | – | 0.02% | 192 |
|
|
2025
Q1 | $518K | Hold |
1,500
| – | – | 0.02% | 192 |
|
|
2024
Q4 | $450K | Hold |
1,500
| – | – | 0.02% | 204 |
|
|
2024
Q3 | $610K | Hold |
1,500
| – | – | 0.03% | 183 |
|
|
2024
Q2 | $482K | Sell |
1,500
-360
| -19% | -$116K | 0.02% | 193 |
|
|
2024
Q1 | $620K | Hold |
1,860
| – | – | 0.03% | 177 |
|
|
2023
Q4 | $503K | Hold |
1,860
| – | – | 0.03% | 182 |
|
|
2023
Q3 | $458K | Hold |
1,860
| – | – | 0.03% | 185 |
|
|
2023
Q2 | $564K | Hold |
1,860
| – | – | 0.03% | 168 |
|
|
2023
Q1 | $490K | Sell |
1,860
-518
| -22% | -$137K | 0.03% | 194 |
|
|
2022
Q4 | $571K | Hold |
2,378
| – | – | 0.04% | 169 |
|
|
2022
Q3 | $437K | Buy |
2,378
+45
| +2% | +$8.27K | 0.03% | 207 |
|
|
2022
Q2 | $392K | Buy |
2,333
+39
| +2% | +$6.55K | 0.03% | 222 |
|
|
2022
Q1 | $575K | Hold |
2,294
| – | – | 0.03% | 208 |
|
|
2021
Q4 | $589K | Hold |
2,294
| – | – | 0.04% | 204 |
|
|
2021
Q3 | $557K | Sell |
2,294
-90
| -4% | -$21.9K | 0.04% | 213 |
|
|
2021
Q2 | $493K | Sell |
2,384
-192
| -7% | -$39.7K | 0.03% | 226 |
|
|
2021
Q1 | $485K | Hold |
2,576
| – | – | 0.04% | 212 |
|
|
2020
Q4 | $424K | Hold |
2,576
| – | – | 0.04% | 216 |
|
|
2020
Q3 | $321K | Buy |
2,576
+11
| +0.4% | +$1.37K | 0.03% | 222 |
|
|
2020
Q2 | $249K | Buy |
+2,565
| New | +$249K | 0.02% | 243 |
|